Skip to main content
Equibles

David Reisinger

Analyst

Lyric Partners

Equibles does not estimate personal net worth.

About David Reisinger

David Reisinger is recorded as Analyst at Lyric Partners. David Reisinger has spoken on 2 earnings calls and 1 other investor event across 3 companies, most recently for Roivant Sciences Ltd. on November 9, 2026. Those appearances were for Roivant Sciences Ltd. (ROIV), AbbVie Inc. (ABBV) and Tectonic Therapeutic, Inc. (TECX). The companies whose calls David Reisinger spoke on are classified in the Healthcare sector.

David Reisinger on recent calls

“So congrats, Matt, to you and the team on a phenomenal quarter. So my question is on Lysraya. Could you talk about the evolution of paid Rx just to help us understand like what percentage of Rx's were paid for in the September quarter, and as of early November, what percentage are paid for today?”
Analyst — Lyric Partners, Roivant 2Q 2026 Earnings Call ·
“Thanks very much, and congrats on the solid fourth quarter and the momentum of the company. I just have one question, which is, you mentioned the psychedelic that's in development.”
Analyst — Lyric Partners, AbbVie Inc. Q4 FY2025 Earnings Call ·
“So congrats, Elise, and team on today's results and on the strong progress in enrollment in APEX.”
Analyst — Lyric Partners, TX45 Phase 1b (Part B) PH-HFrEF Data Conference Call ·

Affiliation history

  • Lyric Partners

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity